You will need to have Administrator rights to your computer to download the Cite While You Write add-in to Microsoft Word in order to use this feature. Use Cite While You Write from EndNote Online to format your in-text citations and bibliography. You can also organize the references you find into folders and share folders with other EndNote Basic users. Create an online account to search, save, and use citations. Add, transfer or import your references to EndNote Online and access your account via any web browser.ĮndNote Online is an option for when access to the EndNote desktop version is not available or you need to collaborate with others who do not have access to EndNote desktop.ĮndNote Online is a free, but limited version of EndNote, and can be used independently of the desktop version. AU - Gall,TMH AU - Gerrard,G AU - Frampton,AE AU - Castellano,L AU - Ahmad,R AU - Habib,N AU - Spalding,D AU - Pai,M AU - Foroni,L AU - Jiao,LR DO - 10.18632/oncotarget.EndNote Online (previously called EndNote Web or EndNote Basic) is a web-based research and writing tool and a complement to the desktop-based EndNote. Circulating miRNA hsa-miR-548ah-5p has the potential to be used as a prognostic biomarker. Conclusions: Medial resection margin status and the frequency of KRAS mutation in the tumour tissue are independent prognostic indicators for resectable PDAC. A circulating miRNA (hsa-miR-548ah-5p) was found to be significantly differentially expressed. Mutational status of cell-free DNA, and number of CTCs, was not found to be useful in this study. Group I patients also trended towards having a KRAS c.35G>A p.Gly12Asp mutation in addition to variants in other genes, such as TP53, CDKN2A, and SMAD4. Group I patients (n = 21) had a higher frequency of the KRAS mutant mean variant allele (16.93% ± 11.04) compared to those in Group II (n = 13 7.55% ± 5.76, p = 0.0078).
Results: Multivariable analysis of clinicopathological factors showed that a positive medial resection margin was significantly associated with short disease-free survival (p = 0.007). Additionally, peripheral blood samples were analysed for variants in cell-free DNA, circulating tumour cells (CTCs), and microRNAs. Ion Torrent high-throughput sequencing on DNA extracted from FFPE tumour samples was used to identify mutations.
Methods: Over a ten-year period, patients with resected PDAC who developed disease recurrence within 12 months (Group I) and those who had no disease recurrence for 24 months (Group II) were identified. We aimed to determine factors which differentiate short and long-term survivors and identify a prognostic biomarker. Download RIS format (EndNote, RefMan) TY - JOUR AB - Objective: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive tumour associated with poor 5-year survival.
0 kommentar(er)
